EverPoint Asset Management’s bluebird bio BLUE Stock Holding History

EverPoint Asset Management’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-7,720	Closed	-$6.78M	–	419
2016 Q3	$6.78M	Sell	7,720 -5,790	-43%	-$4.19M	0.12%	204
2016 Q2	$7.58M	Buy	+13,510	New	+$7.65M	0.15%	179
2015 Q1	–	Sell	-10,036	Closed	-$11.9M	–	505
2014 Q4	$11.9M	Buy	10,036 +1,544	+18%	+$1.03M	0.27%	124
2014 Q3	$3.95M	Buy	8,492 +2,316	+38%	+$1.07M	0.09%	280
2014 Q2	$3.09M	Buy	+6,176	New	+$1.98M	0.06%	349

Other funds holding BLUE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

EverPoint Asset Management's BLUE Position: Q4 2016 in Review

EverPoint Asset Management sold out of bluebird bio (BLUE) in Q4 2016, closing a stake of 7,720 shares — an estimated $6.78M sold.

EverPoint Asset Management first reported a position in BLUE in Q2 2014 and held it in 5 quarters. The position peaked at $11.9M in Q4 2014. 199 funds tracked by Wall St. Rank hold BLUE as of Q4 2016.

EverPoint Asset Management reported no remaining bluebird bio position as of Q4 2016 after selling out during the quarter.
EverPoint Asset Management sold 7,720 bluebird bio shares in Q4 2016, an estimated $6.78M.
EverPoint Asset Management first reported a position in bluebird bio in Q2 2014 and held it in 5 quarters.
EverPoint Asset Management's bluebird bio position peaked at $11.9M in Q4 2014.
199 funds tracked by Wall St. Rank held bluebird bio as of Q4 2016.

Based on EverPoint Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.